Kazia Therapeutics (KZIA) Return on Capital Employed (2009 - 2017)
Kazia Therapeutics (KZIA) posted Return on Capital Employed of 133.31% for Q2 2017, little changed on a QoQ basis from 133.68% in Q4 2016, and down 4994.0% year-over-year from 2.72% in Q2 2016.
Kazia Therapeutics (KZIA) Return on Capital Employed (2009 - 2017) Analysis & Trends
Kazia Therapeutics' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 133.31% for Q2 2017.
- Quarterly Return on Capital Employed fell 4994.0% year-over-year to 133.31% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 133.31% (down 4994.0% YoY) and the FY2025 annual result came in at 27127.84%, down 3063580.0% from the prior year.
- Return on Capital Employed was 133.31% for Q2 2017 at Kazia Therapeutics, roughly flat from 133.68% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 2580.62% in Q4 2014 and bottomed at 133.68% in Q4 2016.
- A 5-year average of 366.66% and a median of 58.17% in 2016 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2014 — Return on Capital Employed soared 257793 bps — and 2015, when it sank 261359 bps.
- Kazia Therapeutics' Return on Capital Employed stood at 2.69% in 2013, then surged by 95697 bps to 2580.62% in 2014, then slumped by 101 bps to 32.97% in 2015, then sank by 305 bps to 133.68% in 2016, then grew by 0 bps to 133.31% in 2017.
- Business Quant data shows KZIA's Return on Capital Employed at 133.31% in Q2 2017, 133.68% in Q4 2016, and 83.38% in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -133.31% |
| Dec 31, 2016 | -133.68% |
| Jun 30, 2016 | -83.38% |
| Dec 31, 2015 | -32.97% |
| Dec 31, 2014 | 2,580.62% |
| Dec 31, 2013 | 2.69% |
| Dec 31, 2012 | -49.95% |
| Dec 31, 2011 | 5.27% |
| Dec 31, 2009 | -118.54% |